Doctor Mich Erlewyn-Lajeunesse | University of Southampton

Publications

19 publications

Page 1 of 2

BSACI Registry for Immunotherapy 7-year report 2025

Mich Erlewyn-Lajeunesse, Maria Smith, Luciano Perfetti Villa, Shifa Shaikh & Olga Maslovskaya, 2025

Type: report

Inequalities in access to specialist allergy services in the United Kingdom: a report from the BSACI Registry for Immunotherapy (BRIT)

Mich Erlewyn-Lajeunesse, Luciano Perfetti Villa, Shifa Shaikh, Maria Smith, Vasiliki Balodima, Sarah Baker, Tom Dawson, Pamela Ewan, Sujoy Khan, Deborah Marriage, Louise Michaelis, Leyla Pur Ozygit, Anna Thursby-Pelham, Amena Warner & Olga Maslovskaya, 2025, Clinical and Experimental Allergy

Type: article

Identification of cow milk epitopes to characterize and quantify disease-specific T cells in allergic children

Sloan A. Lewis, Aaron Sutherland, Ferran Soldevila, Luise Westernberg, Minori Aoki, April Frazier, Synaida Maiche, Mich Erlewyn-Lajeunesse, Hasan Arshad, Leonard Stephanie, Susan Laubach, Jennifer A. Dantzer, Robert A. Wood, Alessandro Sette, Gregory Seumois, Pandurangan Vijayanand & Bjoern Peters, 2023, Journal of Allergy and Clinical Immunology, 152(5), 1196-1209

DOI: 10.1016/j.jaci.2023.07.020

Type: article

Factors affecting delayed gastric emptying and long-term outcomes of children with gastric emptying

Christopher Roberts, Maryam Hussein, Esme Poole, Vinod Kolimarala, Mich Erlewyn-Lajeunesse, R. Mark Beattie, Francis Sundrum & Nadeem Afzal, 2023, Journal of Pediatric Gastroenterology and Nutrition, 76(4), 428-433

DOI: 10.1097/mpg.0000000000003708

Type: article

BSACI 2021 guideline for the management of egg allergy

Susan C. Leech, Pamela W. Ewan, Isabel J. Skypala, Nicola Brathwaite, Mich Erlewyn‐Lajeunesse, Sarah Heath, Heidi Ball, Polly James, Karen Murphy & Andrew T. Clark, 2021, Clinical & Experimental Allergy, 51(10), 1262-1278

DOI: 10.1111/cea.14009

Type: article

Using national registries to identify targeted therapies for refractory urticaria

Sujoy Khan, Louise J. Michaelis, Tom C. Dawson, Anna Thusby-Pelham, Leyla Pur Özyiğit, Mamidipudi Thirumala Krishna & Mich Erlewyn-Lajeunesse, 2021, International Archives of Allergy and Immunology, 182(5), 459-460

DOI: 10.1159/000514689

Type: letterEditorial

Anaphylaxis refractory to intra-muscular adrenaline during in-hospital food challenges

C Alviani, S Burrell, A Macleod, S Edees, G Roberts, P J Turner & M Erlewyn-Lajeunesse, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 50(12), 1400-1405

DOI: 10.1111/cea.13749

Type: article

Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

Jonathan O'B. Hourihane, Kristen Beyer, Allyah Abbas & Michel D.S. Erlewyn-Lajeunesse, 2020, The Lancet Child & Adolescent Health, 4(10)

DOI: 10.1016/s2352-4642(20)30234-0

Type: article

Allergen Immunotherapy in the era of SARS-CoV-2.

E Compalati, M Erlewyn-Lajeunesse, Ali FR, Fernández P Ojeda, Nuñez I Garcia, F Frati & G Mistrello, 2020, Journal of Investigational Allergology & Clinical Immunology

DOI: 10.18176/jiaci.0568

Type: article

Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma

Paul J. Turner, Louise Fleming, Sejal Saglani, Jo Southern, Nick J. Andrews, Elizabeth Miller, Alexandra Adams, Christine Doyle, Michel Erlewyn-Lajeunesse, Katy Fidler, Atul Gupta, Stephen M. Hughes, Andrew Ives, Nicola Jay, Sonal Kansra, Louise Michaelis, Samantha Moss, Clare Murray, Prasad Nagakumar, Graham Roberts, Paul Seddon, Ian Sinha, Gary Stiefel & Huw M. Thomas, 2020, Journal of Allergy and Clinical Immunology, 145(4), 1157-1164.e6

DOI: 10.1016/j.jaci.2019.12.010

Type: article

Dr Mich Erlewyn-Lajeunesse

Connect with Mich

Publications